Jorge J. Castillo

18.0k total citations
373 papers, 8.0k citations indexed

About

Jorge J. Castillo is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jorge J. Castillo has authored 373 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 237 papers in Genetics, 211 papers in Pathology and Forensic Medicine and 111 papers in Oncology. Recurrent topics in Jorge J. Castillo's work include Chronic Lymphocytic Leukemia Research (231 papers), Lymphoma Diagnosis and Treatment (208 papers) and Viral-associated cancers and disorders (82 papers). Jorge J. Castillo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (231 papers), Lymphoma Diagnosis and Treatment (208 papers) and Viral-associated cancers and disorders (82 papers). Jorge J. Castillo collaborates with scholars based in United States, Peru and United Kingdom. Jorge J. Castillo's co-authors include Steven P. Treon, Adam J. Olszewski, Eric S. Winer, Zachary R. Hunter, Roberto N. Miranda, Guang Yang, Kirsten Meid, John L. Reagan, Michele Bibas and Brady Beltrán and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jorge J. Castillo

334 papers receiving 7.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge J. Castillo United States 52 5.0k 3.8k 3.3k 1.6k 1.5k 373 8.0k
Michele Ghielmini Switzerland 31 6.5k 1.3× 3.1k 0.8× 4.5k 1.4× 1.5k 0.9× 696 0.5× 134 8.8k
David J. Inwards United States 49 4.4k 0.9× 2.1k 0.6× 3.8k 1.2× 1.7k 1.1× 1.9k 1.3× 265 8.0k
Grzegorz S. Nowakowski United States 43 3.3k 0.7× 1.6k 0.4× 3.4k 1.0× 1.2k 0.8× 775 0.5× 346 6.3k
Peter Dreger Germany 58 3.7k 0.7× 3.6k 1.0× 4.6k 1.4× 3.2k 2.0× 5.4k 3.6× 408 11.6k
Michael Crump Canada 49 5.6k 1.1× 2.4k 0.6× 5.3k 1.6× 1.2k 0.8× 1.0k 0.7× 310 9.8k
Hanneke C. Kluin‐Nelemans Netherlands 63 6.5k 1.3× 4.2k 1.1× 4.5k 1.4× 3.3k 2.1× 3.2k 2.1× 376 14.0k
Won Seog Kim South Korea 48 7.1k 1.4× 1.8k 0.5× 6.3k 1.9× 3.0k 1.9× 785 0.5× 462 10.8k
Dominique Bordessoule France 39 2.3k 0.5× 1.9k 0.5× 2.2k 0.7× 1.1k 0.7× 2.3k 1.5× 188 6.3k
Anders Österborg Sweden 47 2.5k 0.5× 2.7k 0.7× 2.2k 0.7× 3.2k 2.0× 2.1k 1.4× 204 7.5k
André Bosly Belgium 45 5.8k 1.2× 2.4k 0.6× 4.8k 1.5× 1.1k 0.7× 2.0k 1.3× 191 9.7k

Countries citing papers authored by Jorge J. Castillo

Since Specialization
Citations

This map shows the geographic impact of Jorge J. Castillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge J. Castillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge J. Castillo more than expected).

Fields of papers citing papers by Jorge J. Castillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge J. Castillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge J. Castillo. The network helps show where Jorge J. Castillo may publish in the future.

Co-authorship network of co-authors of Jorge J. Castillo

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge J. Castillo. A scholar is included among the top collaborators of Jorge J. Castillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge J. Castillo. Jorge J. Castillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sawalha, Yazeed, Shayna Sarosiek, Sudip Thapa, et al.. (2025). Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis. Blood Cancer Journal. 15(1). 65–65. 1 indexed citations
3.
4.
Heyman, Benjamin, Stephen Opat, Björn E. Wahlin, et al.. (2024). Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia. Blood Advances. 9(4). 722–728. 3 indexed citations
5.
Castillo, Jorge J., Shayna Sarosiek, Andrew R. Branagan, et al.. (2024). A Phase II Study of Pirtobrutinib and Venetoclax in Previously Treated Patients with Waldenström Macroglobulinemia: An Interim Analysis. Blood. 144(Supplement 1). 3011–3011. 5 indexed citations
6.
Malpica, Luis, Mario L. Marques‐Piubelli, Brady Beltrán, et al.. (2024). EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management. American Journal of Hematology. 99(10). 2002–2015. 5 indexed citations
7.
8.
Bustoros, Mark, Caitlin Gribbin, Jorge J. Castillo, & Richard R. Furman. (2023). Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America. 37(4). e1–e13.
9.
Castillo, Jorge J., et al.. (2022). Bone marrow aspiration in a patient with systemic microsporidium. SHILAP Revista de lepidopterología. 10(5). e05845–e05845. 1 indexed citations
10.
Treon, Steven P., Jorge J. Castillo, Alan P Skarbnik, et al.. (2020). The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients. Blood. 135(21). 1912–1915. 200 indexed citations
11.
Castillo, Jorge J. & Steven P. Treon. (2019). What is new in the treatment of Waldenstrom macroglobulinemia?. Leukemia. 33(11). 2555–2562. 17 indexed citations
12.
Munshi, Manit, Xia Liu, Lian Xu, et al.. (2017). Mutated MYD88 Activates the BCR Component SYK and Provides a Rationale Therapeutic Target in Waldenstrom's Macroglobulinemia. Blood. 130. 2539–2539. 1 indexed citations
13.
D’Sa, Shirley, Marie José Kersten, Jorge J. Castillo, et al.. (2017). Investigation and management of IgM and Waldenström‐associated peripheral neuropathies: recommendations from the IWWM ‐8 consensus panel. British Journal of Haematology. 176(5). 728–742. 47 indexed citations
14.
Olszewski, Adam J., Steven P. Treon, & Jorge J. Castillo. (2017). Application and Outcomes of Bendamustine- or Bortezomib-Based Therapy for Waldenstrom's Macroglobulinemia. Blood. 130. 348–348. 2 indexed citations
15.
Castillo, Jorge J., Joshua Gustine, Kirsten Meid, et al.. (2017). Acquired Von Willebrand Disease in Patients with Waldenström Macroglobulinemia. Blood. 130. 1088–1088. 2 indexed citations
16.
17.
Vos, Josephine M. I., Joshua Gustine, Helmut G. Rennke, et al.. (2016). Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes. British Journal of Haematology. 175(4). 623–630. 56 indexed citations
18.
Quesenberry, Peter J. & Jorge J. Castillo. (2013). Non-Hodgkin lymphoma : prognostic factors and targets. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 1 indexed citations
19.
Olszewski, Adam J. & Jorge J. Castillo. (2013). Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database. Annals of Oncology. 24(5). 1352–1359. 27 indexed citations
20.
Castillo, Jorge J., et al.. (2010). Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood. 116(16). 2897–2907. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele Ghielmini Breakdown of academic impact, for papers by David J. Inwards Breakdown of academic impact, for papers by Grzegorz S. Nowakowski Breakdown of academic impact, for papers by Peter Dreger Breakdown of academic impact, for papers by Michael Crump Breakdown of academic impact, for papers by Hanneke C. Kluin‐Nelemans Breakdown of academic impact, for papers by Won Seog Kim Breakdown of academic impact, for papers by Dominique Bordessoule Breakdown of academic impact, for papers by Anders Österborg Breakdown of academic impact, for papers by André Bosly
Rankless by CCL
2026